You are using an outdated browser. Please upgrade your browser to improve your experience.

atezolizumab

Ligand Summary
Description
A monoclonal antibody that targets programmed death-ligand 1 (CD274 ANTIGEN) and is used to treat urothelial carcinoma, the most common type of bladder cancer.
Synonyms & Links
DrugCentral: 5151
LyCHI:  atezolizumab


loading...
Target Activities